Skip to main content
. 2016 Feb 18;7(12):14925–14939. doi: 10.18632/oncotarget.7483

Figure 6. BRACO-19 treatment leads to a decrease of hTERT expression in the nucleus and translocation to cytoplasm.

Figure 6

a. U87 cells treated with BRACO-19 were stained with the hTERT antibodies for hTERT (green) and DAPI for nucleus (blue). Representative confocal images were shown. Scale bar equals 20 μm. b. Western blot analysis of hTERT phosphorylation in cells exposure to BRACO-19. The levels of hTERT were used as loading control.